PTC Therapeutics
PTCT
PTCT
348 hedge funds and large institutions have $6.52B invested in PTC Therapeutics in 2026 Q1 according to their latest regulatory filings, with 61 funds opening new positions, 144 increasing their positions, 101 reducing their positions, and 55 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding in top 10
Funds holding in top 10: →
0.1% less ownership
Funds ownership: 115.47% → 115.37% (-0.1%)
1% less funds holding
Funds holding: 350 → 348 (-2)
7% less capital invested
Capital invested by funds: $7.04B → $6.52B (-$521M)
Holders
348
Holding in Top 10
7
Calls
$57.5M
Puts
$11.9M
Top Buyers
| 1 | +$166M | |
| 2 | +$46.8M | |
| 3 | +$36.4M | |
| 4 |
Loomis, Sayles & Company
Boston,
Massachusetts
|
+$35M |
| 5 |
Balyasny Asset Management
Chicago,
Illinois
|
+$32.6M |
Top Sellers
| 1 | -$85.7M | |
| 2 | -$78.8M | |
| 3 | -$54.5M | |
| 4 |
ACA
Avoro Capital Advisors
New York
|
-$52M |
| 5 |
AC
Armistice Capital
New York
|
-$51.5M |
